Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan

BMC Public Health

Table 1 Total number and rate of oseltamivir prescription and complication rates from August to December 2009 in Taiwan

	Number of prescriptions (%) (N = 516,283)	Prescription rate per 1000 persons	Influenza with complications per million persons
Age group
0-6	74,432 (14.4)	51.4	139.4
7-12	196,086 (38.0)	116.5	74.5
13-18	133,153 (25.8)	69.0	65.2
19-64	108,473 (21.0)	7.0	28.8
≥65	4,139 (0.8)	1.7	54.1
Region
A	187,655 (36.4)	25.2	64.2
B	111,249 (21.6)	32.1	47.9
C	98,109 (19.0)	21.9	27.5
D	53,929 (10.4)	15.8	28.7
E	53,640 (10.4)	14.3	34.7
F	11,646 (2.3)	20·3	172.6

Note: Region A and B were in northern Taiwan. Region C was in central Taiwan. Region D and E were in southern Taiwan. Region F was in eastern Taiwan. Influenza with complications: influenza danger signs defined by WHO (including symptoms and signs suggesting oxygen impairment, cardiopulmonary insufficiency or central nervous system complications such as shortness of breath, tachypnea, altered mental status etc.).

ISSN: 1471-2458